Changes in fungal taxonomy: mycological rationale and clinical implications.

clinical impact fungal taxonomy medically important fungi molecular identification name changes nomenclature phylogenetics

Journal

Clinical microbiology reviews
ISSN: 1098-6618
Titre abrégé: Clin Microbiol Rev
Pays: United States
ID NLM: 8807282

Informations de publication

Date de publication:
06 Nov 2023
Historique:
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: aheadofprint

Résumé

SUMMARYNumerous fungal species of medical importance have been recently subjected to and will likely continue to undergo nomenclatural changes as a result of the application of molecular approaches to fungal classification together with abandonment of dual nomenclature. Here, we summarize those changes affecting key groups of fungi of medical importance, explaining the mycological (taxonomic) rationale that underpinned the changes and the clinical relevance/importance (where such exists) of the key nomenclatural revisions. Potential mechanisms to mitigate unnecessary taxonomic instability are suggested, together with approaches to raise awareness of important changes to minimize potential clinical confusion.

Identifiants

pubmed: 37930182
doi: 10.1128/cmr.00099-22
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009922

Auteurs

Andrew M Borman (AM)

UK HSA National Mycology Reference Laboratory, Science Quarter, Southmead Hospital, Bristol, United Kingdom.
Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter, United Kingdom.

Elizabeth M Johnson (EM)

UK HSA National Mycology Reference Laboratory, Science Quarter, Southmead Hospital, Bristol, United Kingdom.
Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter, United Kingdom.

Classifications MeSH